Drugs / CoronaVac vaccine
Trials 0
Also used as a comparator or background therapy in 2 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 41 trial | ||||||
| Phase 4 | NCT05343871 Comparator | Jul 2022 → Jul 2023 | COVID-19 | Albert B. Sabin Vaccine Institute | Completed | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT05313074 Comparator | Mar 2021 → Feb 2022 | COVID-19, cancer | National Cancer Institute, Thailand | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CoronaVac vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05313074 ↗ |
| Known as | Sinovac | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05343871 ↗ |
| Modality | Vaccine | “An inactivated virus COVID-19 vaccine” NCT05313074 ↗ |